Evidence map›Paper›PMID 35039540›Full record

ArticleNature communications2022

Single-molecule analysis of specificity and multivalency in binding of short linear substrate motifs to the APC/C.

Nairi Hartooni, Jongmin Sung, Ankur Jain, David O Morgan

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nairi HartooniDepartment of Physiology, University of California, San Francisco, CA, 94143, USA.
Jongmin SungDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, 94143, USA.
Ankur JainDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, 94143, USA.
David O MorganDepartment of Physiology, University of California, San Francisco, CA, 94143, USA. david.morgan@ucsf.edu.ORCID http://orcid.org/0000-0001-8753-4416

Funding

Regulatory Enzymes and Systems in Cell Cycle ControlR35GM118053 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DAVID Owen MORGAN · 2016 to 2026
$10.3M
NIGMS NIH HHS R35 GM118053
6 · The paper itself

Abstract

Robust regulatory signals in the cell often depend on interactions between short linear motifs (SLiMs) and globular proteins. Many of these interactions are poorly characterized because the binding proteins cannot be produced in the amounts needed for traditional methods. To address this problem, we developed a single-molecule off-rate (SMOR) assay based on microscopy of fluorescent ligand binding to immobilized protein partners. We used it to characterize substrate binding to the Anaphase-Promoting Complex/Cyclosome (APC/C), a ubiquitin ligase that triggers chromosome segregation. We find that SLiMs in APC/C substrates (the D box and KEN box) display distinct affinities and specificities for the substrate-binding subunits of the APC/C, and we show that multiple SLiMs in a substrate generate a high-affinity multivalent interaction. The remarkably adaptable substrate-binding mechanisms of the APC/C have the potential to govern the order of substrate destruction in mitosis.

Indexed as

Single Molecule ImagingAmino Acid MotifsAmino Acid SequenceAnaphase-Promoting Complex-CyclosomeAnisotropyHumansImmobilized ProteinsLigandsPeptidesProtein BindingProteolysisSaccharomyces cerevisiaeSubstrate SpecificityAnaphase-Promoting Complex-CyclosomeImmobilized ProteinsLigandsPeptides

Identifiers

PMID35039540
PMCPMC8764033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.